Champions Oncology Files 8-K on Financials
Ticker: CSBR · Form: 8-K · Filed: Jul 18, 2024 · CIK: 771856
| Field | Detail |
|---|---|
| Company | Champions Oncology, INC. (CSBR) |
| Form Type | 8-K |
| Filed Date | Jul 18, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-K
TL;DR
Champions Oncology dropped an 8-K detailing its financials - check it for the latest numbers.
AI Summary
Champions Oncology, Inc. filed an 8-K on July 18, 2024, to report on its results of operations and financial condition, as well as to file financial statements and exhibits. The company, previously known as Champions Biotechnology, Inc., is incorporated in Delaware and is in the biological products sector.
Why It Matters
This filing provides investors with crucial updates on Champions Oncology's financial performance and condition, which can influence investment decisions.
Risk Assessment
Risk Level: low — This is a routine filing of financial information and does not indicate any unusual or immediate risks.
Key Players & Entities
- CHAMPIONS ONCOLOGY, INC. (company) — Registrant
- CHAMPIONS BIOTECHNOLOGY, INC. (company) — Former company name
- CHAMPIONS SPORTS INC (company) — Former company name
- INTERNATIONAL GROUP INC (company) — Former company name
- July 18, 2024 (date) — Date of report
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on the Results of Operations and Financial Condition of Champions Oncology, Inc., and to file Financial Statements and Exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on July 18, 2024.
What is the state of incorporation for Champions Oncology, Inc.?
Champions Oncology, Inc. is incorporated in Delaware.
What was Champions Oncology, Inc. formerly known as?
Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc., Champions Sports Inc, and International Group Inc.
What is the business address of Champions Oncology, Inc.?
The business address of Champions Oncology, Inc. is 855 N. Wolfe Street, Suite 619, Baltimore, MD 21205.
Filing Stats: 461 words · 2 min read · ~2 pages · Grade level 11 · Accepted 2024-07-18 16:13:43
Filing Documents
- csbr-20240718.htm (8-K) — 33KB
- csbr8-k4302024exhibit991.htm (EX-99.1) — 169KB
- fy2016pr_image1a29.jpg (GRAPHIC) — 23KB
- 0001628280-24-032227.txt ( ) — 368KB
- csbr-20240718.xsd (EX-101.SCH) — 2KB
- csbr-20240718_def.xml (EX-101.DEF) — 3KB
- csbr-20240718_lab.xml (EX-101.LAB) — 21KB
- csbr-20240718_pre.xml (EX-101.PRE) — 12KB
- csbr-20240718_htm.xml (XML) — 2KB
02. Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition. On July 18, 2024, Champions Oncology, Inc. (the "Company") issued a press release regarding the Company's audited financial results for its fiscal year ended April 30, 2024. A copy of the Company's press release is attached hereto as Exhibit 99.1. The information contained under Item 2.02 in this Current Report shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits The following exhibit is filed herewith: Exhibit No. 99.1 Press Release dated July 18 , 202 4
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. CHAMPIONS ONCOLOGY, INC. (Registrant) Date: July 18, 2024 By: /s/ Ronnie Morris Ronnie Morris Chief Executive Officer